DOUGLAS KERR, M.D.
Neurology at Wolfe St, Baltimore, MD
License number
Maryland D54315
Category
Neurology
Type
Neurology
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-9441
Personal information
See more information about DOUGLAS KERR at radaris.comName
Address
Phone
425 Latimer Rd, Joppa, MD 21085
625 Maid Marion Rd, Annapolis, MD 21405
1269 Limit Ave, Baltimore, MD 21239
1436 Hallowell Ln, New Windsor, MD 21776
103 Murdock Rd, Baltimore, MD 21212
Organization information
See more information about DOUGLAS KERR at bizstanding.comDouglas Kerr MD,PHD
600 N Wolfe St, Baltimore, MD 21287
Industry:
Neurologist, Neurosurgeon
Site:
Phone:
(410) 955-2244 (Phone)
Description:
HTTP://WWW.ABMS.ORG
Douglas Anthony Kerr
Professional information
See more information about DOUGLAS KERR at trustoria.com
Dr. Douglas Kerr, Baltimore MD - MD (Doctor of Medicine)
Dr. Douglas Kerr, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Neurology
Address:
600 N Wolfe St, Baltimore 21287
(410) 955-9441 (Phone)
(410) 955-9441 (Phone)
Languages:
English
Hospitals:
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
Thomas Jefferson University
Graduate Hospital
Johns Hopkins University School Med
Thomas Jefferson University
Graduate Hospital
Johns Hopkins University School Med
Risk Manager - City Of Baltimore
Risk Manager - City Of Baltimore
Position:
Risk Manager at City of Baltimore
Location:
Baltimore, Maryland Area
Industry:
Government Administration
Work:
City of Baltimore
- City of Baltimore since Oct 2006
-
Risk Manager
GatesMcDonald
- Baltimore, Maryland Area Sep 2005 - Jun 2006
-
National Claims Manager, American Red Cross Account
Schoenfeld Insurance Associates, Inc.
- Baltimore, Maryland Area Nov 2004 - Jun 2005
-
Account Executive / Producer
Riggs, Counselman, Michaels and Downes, Inc.
- Baltimore, Maryland Area May 1998 - Nov 2004
-
VP - Claims Manager
Willis
- Bethesda, MD May 1997 - May 1998
-
AVP - Senior Claims Specialist
Browning-Ferris, Industries (now Allied Waste(
- Baltimore, Maryland Area, Atlanta, GA, Houston, TX Jun 1990 - May 1997
-
Regional Claims Manager
Education:
University of Maryland College Park
Associate Professor At Johns Hopkins Hospital
Associate Professor At Johns Hopkins Hospital
Position:
Associate Professor at Johns Hopkins Hospital
Location:
Baltimore, Maryland Area
Industry:
Hospital & Health Care
Work:
Johns Hopkins Hospital
-
Associate Professor
Douglas A Kerr, Baltimore MD
Douglas A Kerr, Baltimore MD
Specialties:
Neurologist
Address:
600 N Wolfe St, Baltimore, MD 21287
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Douglas Kerr
Douglas Kerr
Location:
Baltimore, Maryland Area
Industry:
Information Technology and Services
Douglas Anthony Kerr, Baltimore MD
Douglas Anthony Kerr, Baltimore MD
Specialties:
Neurology, Psychiatry, Pulmonary Disease
Work:
JHU Neurology
600 N Wolfe St, Baltimore, MD 21287
600 N Wolfe St, Baltimore, MD 21287
Education:
Thomas Jefferson University (1995)
Methods Of Treating Neurological Autoimmune Disorders With Cyclophosphamide
Methods Of Treating Neurological Autoimmune Disorders With Cyclophosphamide
US Patent:
2011012, May 26, 2011
Filed:
Oct 1, 2008
Appl. No.:
12/681237
Inventors:
Adam Ian Kaplin - Baltimore MD, US
Douglas Kerr - Ruxton MD, US
Peter Arthur Calabresi - Lutherville MD, US
Sithy Rameeza Allie - Lebanon NH, US
Douglas Kerr - Ruxton MD, US
Peter Arthur Calabresi - Lutherville MD, US
Sithy Rameeza Allie - Lebanon NH, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 38/19, C12Q 1/32, C07F 9/6584, A61K 31/675, A61P 25/00, A61P 25/18
US Classification:
424 851, 435 26, 564 13, 514110
Abstract:
Described herein are methods for treating neurological autoimmune disorders in which the treatment method includes administering an immunoablative agent to eliminate most or essentially all maturing and mature elements of the immune system in an affected individual. Following this step, the individual is administered agents to reestablish the ablated immune system.
Cell-Based Compositions And Methods For Treating Conditions Of The Nervous System
Cell-Based Compositions And Methods For Treating Conditions Of The Nervous System
US Patent:
2009015, Jun 18, 2009
Filed:
Aug 14, 2008
Appl. No.:
12/192051
Inventors:
Douglas A. Kerr - Ruxton MD, US
Michael Gorelik - Reisterstown MD, US
Michael Levy - Phoenix MD, US
Michael Gorelik - Reisterstown MD, US
Michael Levy - Phoenix MD, US
Assignee:
The Johns Hopkins University - Baltimore MD
International Classification:
A61K 45/00, A61P 25/28
US Classification:
424 937
Abstract:
Disclosed herein are cell-based compositions for the treatment of conditions of the nervous system and methods for their use. In one embodiment, a cell-based composition comprises glial-restricted progenitors (GRPs) genetically modified to express a targeting ligand on their cell surface. Methods for the preparation of such cell-based compositions are disclosed. Also disclosed is a method for treating a subject suffering from a condition of the central nervous system by providing therapeutic cells (e.g., GRPs) through an intra-arterial route of administration.
Mntf Differentiation And Growth Of Stem Cells
Mntf Differentiation And Growth Of Stem Cells
US Patent:
2009011, May 7, 2009
Filed:
Nov 10, 2006
Appl. No.:
12/093452
Inventors:
Deepa M. Deshpande - Baltimore MD, US
Douglas A. Kerr - Ruxton MD, US
Dorothy Pui-Yuk Ko - Monterey Park CA, US
Douglas A. Kerr - Ruxton MD, US
Dorothy Pui-Yuk Ko - Monterey Park CA, US
Assignee:
GENERVON BIOPHARMACEUTICALS LLC - Montebello CA
International Classification:
A61K 35/12, A61K 38/08, A61K 38/10, C12N 5/06, A61K 38/16
US Classification:
424 937, 514 17, 514 16, 514 15, 514 14, 514 13, 514 12, 435377
Abstract:
The present invention provides methods for inducing differentiation of an embryonic stem cell into a motor neuron using a motoneuronotrophic factor (MNTF) or its peptide analogues. The present invention further provides a method for isolating a population of stem cell derived motor neurons and a population of cells comprising the differentiated neural cells. Additionally, the present invention is directed to a method of enhancing the survival of the differentiated neural cells in long term cell cultures. Finally, the present invention provides compositions containing MNTF or its peptide analogs for therapeutic use in conjunction with stem cells.